This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Non surgical under eye filler treatment focuses on natural correction, precise technique, and conservative aesthetic ...
Medicare offers limited coverage for eye care. If a person is experiencing symptoms of dry eye disease that affect their vision, a doctor may consider treatment medically necessary, and if so, ...
With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." For the weeks leading up to my 34th birthday back in June, I was strongly considering under-eye filler. I ...
Pharmacological options for the treatment of dry eye syndrome (DES) include both topical agents (typically the preferred form of pharmacologic treatment) and oral systemic drugs. Drugs used in topical ...
Pain behind the eye can result from eyestrain, migraine, dental problems, glaucoma, giant cell arteritis, and other causes. Treatment will depend on the cause, but applying cool or warm compresses may ...
The symptoms of dry eye are multifactorial, says Mina Massaro-Giordano, MD, making identifying and treating dry eye important for quality of life. Massaro-Giordano: Taking the newest definition, the ...
InvestorsHub on MSN
Aldeyra receives FDA rejection for dry eye treatment reproxalap
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) said it has received a Complete Response Letter from the U.S. Food and Drug Administration rejecting its New Drug Application for reproxalap, a proposed ...
Aldeyra Therapeutics Inc. ALDX shares are tumbling on Tuesday following the U.S. Food and Drug Administration (FDA) update.
Thyroid eye disease (TED), also known as Graves’ eye disease or Graves’ ophthalmopathy, is an inflammatory condition in people with thyroid disease. Treatment may include medication, eye drops, and ...
The Food and Drug Administration approved a virtual reality-based treatment for children with the visual disorder amblyopia, or lazy eye, the company behind the therapy announced today. Patients watch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results